Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-06-10 | New | $400,000 | $400,000 | Debt Only | 06b | SEC link |
| 2023-08-11 | Amended | $4,250,005 | $1,550,005 | Equity Only | 06b | SEC link |
| 2023-02-08 | New | $2,700,000 | $2,700,000 | Equity Only | 06b | SEC link |
| 2021-02-08 | New | $1,125,000 | $1,125,000 | Other | 06b | SEC link |
| Name | Role |
|---|---|
| Robert Ashley | Director |
| Joe Gatto | Director |
| Jing Zhou Hou | Director, Executive, Promoter |
| Song Li | Director, Promoter |
| Lusong Luo | Director |
| Victoria Manax | Director |
| Stanley Marks | Director |
| Sam Rothstein | Director, Executive, Promoter |
| Jingjing Sun | Promoter |
| Stephen Thorne | Executive, Promoter |